NPI: 1982941290 · BROOKLYN, NY 11208 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/07/2013
| Authorized Official | MAIER, KENNETH (VICE PRESIDENT FINANCE) |
| NPI Enumeration Date | 01/07/2013 |
Other providers sharing the same authorized official: MAIER, KENNETH
| Provider | City | State | Total Paid |
|---|---|---|---|
| THE ROGOSIN INSTITUTE, INC. | NEW YORK | NY | $3.42M |
| THE ROGOSIN INSTITUTE INC | BROOKLYN | NY | $1.05M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,397 | $576K |
| 2019 | 31,194 | $861K |
| 2020 | 45,916 | $1.21M |
| 2021 | 28,191 | $569K |
| 2022 | 17,712 | $475K |
| 2023 | 7,129 | $379K |
| 2024 | 7,995 | $282K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 10,343 | 1,289 | $1.72M |
| A4657 | Syringe, with or without needle, each | 81,989 | 2,521 | $1.39M |
| J3490 | Unclassified drugs | 50,772 | 1,280 | $977K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 15,377 | 460 | $238K |
| J1644 | Injection, heparin sodium, per 1000 units | 1,128 | 89 | $24K |
| 83540 | 352 | 67 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 345 | 40 | $1K |
| J1756 | Injection, iron sucrose, 1 mg | 228 | 37 | $486.00 |